{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:09:26Z","timestamp":1791803366053,"version":"4.3.4"},"reference-count":214,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Dermatology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.yadr.2008.09.009","type":"journal-article","created":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T06:50:40Z","timestamp":1227682240000},"page":"125-169","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Management of Childhood Psoriasis"],"prefix":"10.1016","volume":"24","author":[{"given":"Kelly M.","family":"Cordoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2133.2006.07185.x","article-title":"A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases","volume":"155","author":"Beattie","year":"2006","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.clindermatol.2007.08.009","article-title":"Childhood psoriasis","volume":"25","author":"Benoit","year":"2007","journal-title":"Clin Dermatol"},{"issue":"5","key":"10.1016\/j.yadr.2008.09.009_bib3","first-page":"309","article-title":"Childhood psoriasis","volume":"64","author":"Farber","year":"1999","journal-title":"Cutis"},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000251595","article-title":"The natural history of psoriasis in 5,600 patients","volume":"148","author":"Farber","year":"1974","journal-title":"Dermatologica"},{"issue":"9","key":"10.1016\/j.yadr.2008.09.009_bib5","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1365-4632.2004.02182.x","article-title":"Epidemiology of childhood psoriasis: a study of 419 patients from northern India","volume":"43","author":"Kumar","year":"2004","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.yadr.2008.09.009_bib6","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1396-0296.2004.04039.x","article-title":"Pediatric psoriasis and psoriatic arthritis","volume":"17","author":"Lewkowicz","year":"2004","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1525-1470.2001.018003188.x","article-title":"Childhood psoriasis: a clinical review of 1262 cases","volume":"18","author":"Morris","year":"2001","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/00008480-200208000-00008","article-title":"Childhood psoriasis","volume":"14","author":"Rogers","year":"2002","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1525-1470.2000.01746.x","article-title":"A comparative study of pediatric onset psoriasis with adult onset psoriasis","volume":"17","author":"Raychaudhuri","year":"2000","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.yadr.2008.09.009_bib10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2230.1999.00497.x","article-title":"Management of psoriasis in childhood","volume":"24","author":"Burden","year":"1999","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2133.1975.tb03077.x","article-title":"Psoriasiform napkin dermatitis\u2014a follow-up study","volume":"92","author":"Neville","year":"1975","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib12","first-page":"534","article-title":"Psoriasiform napkin dermatitis","volume":"66","author":"Boje Rasmussen","year":"1986","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1525-1470.1986.tb00520.x","article-title":"Infantile psoriasis: a follow-up study","volume":"3","author":"Farber","year":"1986","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1365-2133.1996.tb01501.x","article-title":"Safety and efficacy of calcipotriol ointment (Dovonex) in treating children with psoriasis vulgaris","volume":"135","author":"Darley","year":"1996","journal-title":"Br J Dermatol"},{"issue":"5 Suppl","key":"10.1016\/j.yadr.2008.09.009_bib15","doi-asserted-by":"crossref","first-page":"32S","DOI":"10.1111\/1523-1747.ep12505715","article-title":"The role of immune system in the pathogenesis of psoriasis","volume":"95","author":"Baadsgaard","year":"1990","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib16","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1046\/j.1365-2249.2001.01563.x","article-title":"Skin T cell proliferative response to M protein and other cell wall and membrane proteins of group A streptococci in chronic plaque psoriasis","volume":"124","author":"Baker","year":"2001","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s004030100218","article-title":"Non-M protein(s) on the cell wall and membrane of group A streptococci induce(s) IFN-gamma production by dermal CD4+ T cells in psoriasis","volume":"293","author":"Brown","year":"2001","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib18","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1067\/mpd.2000.107840","article-title":"Psoriatic eruption in Kawasaki disease","volume":"137","author":"Eberhard","year":"2000","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib19","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1046\/j.1365-2133.2000.03376.x","article-title":"A case of guttate psoriasis following Kawasaki disease","volume":"142","author":"Han","year":"2000","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.yadr.2008.09.009_bib20","first-page":"153","article-title":"The relationship between infection with group A beta hemolytic streptococci and the development of psoriasis","volume":"19","author":"Rasmussen","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.yadr.2008.09.009_bib21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/archderm.1974.01630020023005","article-title":"Natural history of psoriasis in 61 twin pairs","volume":"109","author":"Farber","year":"1974","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.yadr.2008.09.009_bib22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.1365-2133.2000.03761.x","article-title":"Identifying a gene for psoriasis on chromosome 6 (Psors1)","volume":"143","author":"Burden","year":"2000","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib23","first-page":"273","article-title":"Evidence that HLA-Cw6 determines early onset of psoriasis, obtained using sequence-specific primers (PCR-SSP)","volume":"77","author":"Enerback","year":"1997","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"10.1016\/j.yadr.2008.09.009_bib24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF02507104","article-title":"HLA risk haplotype Cw6,DR7,DQA1*0201 and HLA-Cw6 with reference to the clinical picture of psoriasis vulgaris","volume":"288","author":"Ikaheimo","year":"1996","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"10.1016\/j.yadr.2008.09.009_bib25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1086\/503821","article-title":"Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene","volume":"78","author":"Nair","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.yadr.2008.09.009_bib26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2133.1980.tb05690.x","article-title":"Psoriasis and HLA-Cw6","volume":"102","author":"Tiilikainen","year":"1980","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib27","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/0092-8674(95)90211-2","article-title":"Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis","volume":"83","author":"Carroll","year":"1995","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.yadr.2008.09.009_bib28","first-page":"1321","article-title":"Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin","volume":"151","author":"Wrone-Smith","year":"1997","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib29","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1046\/j.1365-2133.1999.03205.x","article-title":"Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis","volume":"141","author":"Bhushan","year":"1999","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.yadr.2008.09.009_bib30","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.4049\/jimmunol.155.8.4078","article-title":"Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris","volume":"155","author":"Menssen","year":"1995","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.yadr.2008.09.009_bib31","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1172\/JCI118263","article-title":"Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis","volume":"96","author":"Leung","year":"1995","journal-title":"J Clin Invest"},{"issue":"985","key":"10.1016\/j.yadr.2008.09.009_bib32","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/pgmj.2007.061473","article-title":"Psoriasis: advances in pathophysiology and management","volume":"83","author":"MacDonald","year":"2007","journal-title":"Postgrad Med J"},{"issue":"5","key":"10.1016\/j.yadr.2008.09.009_bib33","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jaad.2008.02.040","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics","volume":"58","author":"Gottlieb","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/art.23240","article-title":"Comparison of Vancouver and International League of Associations for Rheumatology classification criteria for juvenile psoriatic arthritis","volume":"59","author":"Stoll","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib35","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1067\/mjd.2002.120470","article-title":"Psoriasis of early and late onset: a clinical and epidemiologic study from Spain","volume":"46","author":"Ferrandiz","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.yadr.2008.09.009_bib36","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/archderm.139.11.1425","article-title":"Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom","volume":"139","author":"Gelfand","year":"2003","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib37","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2340\/00015555-0297","article-title":"Psoriasis and the metabolic syndrome","volume":"87","author":"Cohen","year":"2007","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.yadr.2008.09.009_bib38","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000111512","article-title":"Association between psoriasis and the metabolic syndrome. A cross-sectional study","volume":"216","author":"Cohen","year":"2008","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib39","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2133.1982.tb01731.x","article-title":"Further evidence for an association between psoriasis, Crohn's disease and ulcerative colitis","volume":"106","author":"Yates","year":"1982","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.yadr.2008.09.009_bib40","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s004310000500","article-title":"Synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome in childhood: a report of ten cases and review of the literature","volume":"159","author":"Beretta-Piccoli","year":"2000","journal-title":"Eur J\u00a0Pediatr"},{"issue":"5 Pt 1","key":"10.1016\/j.yadr.2008.09.009_bib41","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0190-9622(86)70265-X","article-title":"Drugs in exacerbation of psoriasis","volume":"15","author":"Abel","year":"1986","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib42","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1046\/j.1365-2133.2000.03885.x","article-title":"HLA-C and guttate psoriasis","volume":"143","author":"Mallon","year":"2000","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib43","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/archderm.1996.03890300147032","article-title":"How great is the risk of further psoriasis following a single episode of acute guttate psoriasis?","volume":"132","author":"Martin","year":"1996","journal-title":"Arch Dermatol"},{"issue":"22","key":"10.1016\/j.yadr.2008.09.009_bib44","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJM198511283132210","article-title":"AIDS exacerbates psoriasis","volume":"313","author":"Johnson","year":"1985","journal-title":"N Engl J Med"},{"issue":"1 Pt 1","key":"10.1016\/j.yadr.2008.09.009_bib45","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0190-9622(88)80053-7","article-title":"Acquired immunodeficiency syndrome (AIDS) can exacerbate psoriasis","volume":"18","author":"Lazar","year":"1988","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib46","first-page":"527","article-title":"Clobetasol propionate for psoriasis: are ointments really more potent?","volume":"5","author":"Warino","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.yadr.2008.09.009_bib47","series-title":"Therapy of moderate to severe psoriasis","first-page":"179","article-title":"Combination, rotational and sequential therapy","author":"Lebwohl","year":"2003"},{"issue":"9","key":"10.1016\/j.yadr.2008.09.009_bib48","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2165\/00128072-200103090-00005","article-title":"Psoriasis in children: a guide to its diagnosis and management","volume":"3","author":"Leman","year":"2001","journal-title":"Paediatr Drugs"},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archderm.1985.01660010067020","article-title":"Correlation of the vasoconstriction assay and clinical activity in psoriasis","volume":"121","author":"Cornell","year":"1985","journal-title":"Arch Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.yadr.2008.09.009_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-4362.1992.tb04008.x","article-title":"Issues in measuring percutaneous absorption of topical corticosteroids","volume":"31","author":"Maibach","year":"1992","journal-title":"Int J Dermatol."},{"issue":"Suppl 1","key":"10.1016\/j.yadr.2008.09.009_bib51","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.jaad.2005.04.031","article-title":"A clinician's paradigm in the treatment of psoriasis","volume":"53 1","author":"Lebwohl","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.clindermatol.2005.09.003","article-title":"Tachyphylaxis to topical corticosteroids: the more you use them, the less they work?","volume":"24","author":"Feldman","year":"2006","journal-title":"Clin Dermatol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib53","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2230.1981.tb02370.x","article-title":"Tar and related compounds in the therapy of psoriasis","volume":"6","author":"Comaish","year":"1981","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib54","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-4362.1985.tb05762.x","article-title":"Tar revisited","volume":"24","author":"Lin","year":"1985","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib55","first-page":"1197","article-title":"Psoriasis: treatment with a tar gel","volume":"17","author":"Cram","year":"1976","journal-title":"Cutis"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib56","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2165\/00003495-198428040-00003","article-title":"A review of recent advances in treatment","volume":"28","author":"Farber","year":"1984","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.yadr.2008.09.009_bib57","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archderm.1982.01650190041016","article-title":"New coal tar extract and coal tar shampoos. Evaluation by epidermal cell DNA synthesis suppression assay","volume":"118","author":"Lowe","year":"1982","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib58","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1525-1470.2007.00548.x","article-title":"Immunologic changes in TNF-alpha, sE-selectin, sP-selectin, sICAM-1, and IL-8 in pediatric patients treated for psoriasis with the Goeckerman regimen","volume":"24","author":"Borska","year":"2007","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib59","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archderm.1978.01640130007001","article-title":"Crude coal tar plus near ultraviolet light suppresses DNA synthesis in epidermis","volume":"114","author":"Stoughton","year":"1978","journal-title":"Arch Dermatol"},{"issue":"10","key":"10.1016\/j.yadr.2008.09.009_bib60","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1046\/j.1365-4362.2003.01974.x","article-title":"Calcipotriol versus coal tar: a prospective randomized study in stable plaque psoriasis","volume":"42","author":"Sharma","year":"2003","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib61","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2165\/00002018-199615060-00002","article-title":"Coal tar therapy. Is it carcinogenic?","volume":"15","author":"van Schooten","year":"1996","journal-title":"Drug Saf"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib62","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1524-4725.1995.tb00158.x","article-title":"Is dermatologic usage of coal tar carcinogenic? A review of the literature","volume":"21","author":"Pion","year":"1995","journal-title":"Dermatol Surg"},{"issue":"8","key":"10.1016\/j.yadr.2008.09.009_bib63","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archderm.1981.01650080019020","article-title":"Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study","volume":"117","author":"Pittelkow","year":"1981","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.yadr.2008.09.009_bib64","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0190-9622(83)70125-8","article-title":"Anthralin: historical and current perspectives","volume":"9","author":"Ashton","year":"1983","journal-title":"J Am Acad Dermatol"},{"issue":"4836","key":"10.1016\/j.yadr.2008.09.009_bib65","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/bmj.2.4836.591","article-title":"The approach to psoriasis","volume":"2","author":"Ingram","year":"1953","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.yadr.2008.09.009_bib66","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/1523-1747.ep12275369","article-title":"Antirespiratory and antiproliferative activity of anthralin in cultured human keratinocytes","volume":"84","author":"Reichert","year":"1985","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib67","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1046\/j.1523-1747.2000.00934.x","article-title":"Anti-psoriatic drug anthralin activates JNK via lipid peroxidation: mononuclear cells are more sensitive than keratinocytes","volume":"114","author":"Peus","year":"2000","journal-title":"J Invest Dermatol"},{"issue":"11","key":"10.1016\/j.yadr.2008.09.009_bib68","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1365-4362.1994.tb01005.x","article-title":"Efficacy of short-contact therapy with dithranol in childhood psoriasis","volume":"33","author":"Zvulunov","year":"1994","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.yadr.2008.09.009_bib69","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2133.1982.tb00922.x","article-title":"Short-duration ('minutes') therapy with dithranol for psoriasis: a new out-patient regimen","volume":"106","author":"Runne","year":"1982","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib70","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1185\/03007998309111752","article-title":"An open assessment of 0.1% dithranol in a 17% urea base ('Psoradrate' 0.1%) in the treatment of psoriasis of children","volume":"8","author":"Guerrier","year":"1983","journal-title":"Curr Med Res Opin"},{"issue":"9","key":"10.1016\/j.yadr.2008.09.009_bib71","first-page":"1","article-title":"New developments in topical sequential therapy for psoriasis","volume":"10","author":"Koo","year":"2005","journal-title":"Skin Therapy Lett"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib72","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1067\/mjd.2001.117046","article-title":"Treatment of psoriasis. Part 1. Topical therapy and phototherapy","volume":"45","author":"Lebwohl","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib73","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0190-9622(97)70320-7","article-title":"Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skin","volume":"36","author":"Reichrath","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib74","first-page":"268","article-title":"Topical calcitriol (1,25-dihydroxyvitamin D3) treatment of psoriasis: an immunohistological evaluation","volume":"77","author":"Reichrath","year":"1997","journal-title":"Acta Derm Venereol"},{"issue":"2 Pt 1","key":"10.1016\/j.yadr.2008.09.009_bib75","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0190-9622(96)90349-7","article-title":"A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis","volume":"35","author":"Lebwohl","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib76","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jaad.2006.05.026","article-title":"A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes","volume":"55","author":"Koo","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib77","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00128071-200607030-00004","article-title":"Use of calcipotriene cream (Dovonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene\/betamethasone dipropionate two-compound product (Taclonex): a randomized, parallel-group clinical trial","volume":"7","author":"White","year":"2006","journal-title":"Am J Clin Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/j.yadr.2008.09.009_bib78","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0190-9622(97)70281-0","article-title":"Topical calcipotriol in childhood psoriasis","volume":"36","author":"Oranje","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib79","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1046\/j.1525-1470.2000.00024-3.x","article-title":"Infantile psoriasis: successful treatment with topical calcipotriol","volume":"17","author":"Choi","year":"2000","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.yadr.2008.09.009_bib80","first-page":"341","article-title":"Psoriasis in infancy: therapy with calcipotriene ointment","volume":"68","author":"Travis","year":"2001","journal-title":"Cutis"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib81","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0190-9622(97)70067-7","article-title":"The effects of topical calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis","volume":"37","author":"Bourke","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib82","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0190-9622(94)70066-4","article-title":"Response of psoriasis to a new topical retinoid, AGN 190168","volume":"30","author":"Esgleyes-Ribot","year":"1994","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 49","key":"10.1016\/j.yadr.2008.09.009_bib83","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2133.1996.tb15663.x","article-title":"Early clinical development of tazarotene","volume":"135","author":"Marks","year":"1996","journal-title":"Br J Dermatol"},{"issue":"4 Pt 1","key":"10.1016\/j.yadr.2008.09.009_bib84","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0190-9622(98)70008-8","article-title":"Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis","volume":"39","author":"Lebwohl","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib85","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-2133.2003.05392.x","article-title":"Tazarotene 0.1% gel for psoriasis of the fingernails and toenails: an open, prospective study","volume":"149","author":"Bianchi","year":"2003","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib86","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1525-1470.2007.00421.x","article-title":"Childhood nail psoriasis: a useful treatment with tazarotene 0.05%","volume":"24","author":"Diluvio","year":"2007","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.yadr.2008.09.009_bib87","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1067\/mjd.2002.120942","article-title":"Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis","volume":"46","author":"Nghiem","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.yadr.2008.09.009_bib88","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/archderm.141.9.1152","article-title":"Pimecrolimus and tacrolimus for the treatment of intertriginous and facial psoriasis: are they effective?","volume":"141","author":"Bigby","year":"2005","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.yadr.2008.09.009_bib89","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2133.2003.05426.x","article-title":"Topical tacrolimus for facial psoriasis","volume":"149","author":"Clayton","year":"2003","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib90","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1067\/mjd.2003.169","article-title":"Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas","volume":"48","author":"Freeman","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.yadr.2008.09.009_bib91","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jaad.2004.06.010","article-title":"Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study","volume":"51","author":"Gribetz","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.yadr.2008.09.009_bib92","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/archderm.142.9.1138","article-title":"1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study","volume":"142","author":"Kreuter","year":"2006","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.yadr.2008.09.009_bib93","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaad.2004.07.011","article-title":"Tacrolimus ointment is effective for facial and intertriginous psoriasis","volume":"51","author":"Lebwohl","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib94","first-page":"451","article-title":"Topical tacrolimus is effective for facial lesions of psoriasis","volume":"80","author":"Yamamoto","year":"2000","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.yadr.2008.09.009_bib95","first-page":"471","article-title":"Topical tacrolimus: an effective therapy for facial psoriasis","volume":"13","author":"Yamamoto","year":"2003","journal-title":"Eur J\u00a0Dermatol"},{"issue":"9","key":"10.1016\/j.yadr.2008.09.009_bib96","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1468-3083.2006.01630.x","article-title":"Successful treatment with topical tacrolimus for oral psoriasis","volume":"20","author":"Yamamoto","year":"2006","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.yadr.2008.09.009_bib97","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1468-3083.2006.01680.x","article-title":"A case of infantile psoriasis with pseudoainhum successfully treated with topical pimecrolimus and low-dose narrowband UVB phototherapy","volume":"20","author":"Ahn","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib98","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1468-3083.2004.01054.x","article-title":"Psoriasis of the glans penis in a child successfully treated with Elidel (pimecrolimus) cream","volume":"18","author":"Amichai","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib99","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1525-1470.2007.00341.x","article-title":"Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients","volume":"24","author":"Brune","year":"2007","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.yadr.2008.09.009_bib100","first-page":"7","article-title":"Pimecrolimus 1 percent cream in the treatment of psoriasis in a child","volume":"12","author":"Mansouri","year":"2006","journal-title":"Dermatol Online J"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib101","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jaad.2005.05.036","article-title":"Topical tacrolimus in the treatment of inverse psoriasis in children","volume":"53","author":"Steele","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"5 Pt 1","key":"10.1016\/j.yadr.2008.09.009_bib102","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0190-9622(89)70286-3","article-title":"Topical corticosteroid compounding: effects on physicochemical stability and skin penetration rate","volume":"21","author":"Krochmal","year":"1989","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib103","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1001\/archderm.1975.01630180068008","article-title":"Percutaneous absorption of salicylic acid","volume":"111","author":"Taylor","year":"1975","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.yadr.2008.09.009_bib104","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1067\/mjd.2001.117047","article-title":"Treatment of psoriasis. Part 2. Systemic therapies","volume":"45","author":"Lebwohl","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"3 Pt 2","key":"10.1016\/j.yadr.2008.09.009_bib105","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/S0190-9622(99)70363-4","article-title":"Systemic sequential therapy of psoriasis: a new paradigm for improved therapeutic results","volume":"41","author":"Koo","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"1 Suppl 2","key":"10.1016\/j.yadr.2008.09.009_bib106","first-page":"11","article-title":"Using topical multimodal strategies for patients with psoriasis","volume":"79","author":"Koo","year":"2007","journal-title":"Cutis"},{"key":"10.1016\/j.yadr.2008.09.009_bib107","series-title":"Comprehensive dermatologic drug therapy","first-page":"275","article-title":"Systemic retinoids","author":"Patton","year":"2007"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib108","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1365-2133.2004.06181.x","article-title":"Successful use of acitretin in conjunction with narrowband ultraviolet B phototherapy in a child with severe pustular psoriasis, von Zumbusch type","volume":"151","author":"Kopp","year":"2004","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.yadr.2008.09.009_bib109","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1517\/14656566.6.10.1725","article-title":"A review of acitretin, a systemic retinoid for the treatment of psoriasis","volume":"6","author":"Lee","year":"2005","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib110","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1525-1470.1988.tb00902.x","article-title":"Etretinate in severe psoriasis of children","volume":"5","author":"Rosinska","year":"1988","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.yadr.2008.09.009_bib111","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archderm.1987.01660260100023","article-title":"Etretinate therapy for generalized pustular psoriasis in children","volume":"123","author":"Shelnitz","year":"1987","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.yadr.2008.09.009_bib112","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1525-1470.2007.00524.x","article-title":"Childhood generalized pustular psoriasis: successful treatment with isotretinoin","volume":"24","author":"Al-Shobaili","year":"2007","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib113","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1365-2133.1996.tb07936.x","article-title":"An appraisal of acitretin therapy in children with inherited disorders of keratinization","volume":"134","author":"Lacour","year":"1996","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.yadr.2008.09.009_bib114","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1067\/S0190-9622(03)01564-0","article-title":"Oral retinoid therapy for dermatologic conditions in children and adolescents","volume":"49","author":"Brecher","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib115","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-4362.1989.tb04806.x","article-title":"Ocular side effects of the retinoids","volume":"28","author":"Gold","year":"1989","journal-title":"Int J Dermatol"},{"issue":"12","key":"10.1016\/j.yadr.2008.09.009_bib116","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/archderm.1983.01650360033009","article-title":"Changes in plasma cholesterol and triglyceride levels after treatment with oral isotretinoin. A prospective study","volume":"119","author":"Zech","year":"1983","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.yadr.2008.09.009_bib117","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1365-4362.1997.00331.x","article-title":"Variations in lipid and lipoprotein levels during isotretinoin treatment for acne vulgaris with special emphasis on HDL-cholesterol","volume":"36","author":"Lestringant","year":"1997","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib118","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0049-0172(95)80039-5","article-title":"Rheumatologic complications of vitamin A and retinoids","volume":"24","author":"Nesher","year":"1995","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib119","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2310\/7750.2006.00065","article-title":"Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature","volume":"10","author":"Halverstam","year":"2006","journal-title":"J Cutan Med Surg"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib120","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0733-8635(05)70252-7","article-title":"The use of retinoids in the pediatric patient","volume":"16","author":"Ruiz-Maldonado","year":"1998","journal-title":"Dermatol Clin"},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib121","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1517\/14740338.4.1.129","article-title":"Efficacy and safety of oral retinoids in psoriasis","volume":"4","author":"Van Zander","year":"2005","journal-title":"Expert Opin Drug Saf"},{"issue":"5","key":"10.1016\/j.yadr.2008.09.009_bib122","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0190-9622(82)70148-3","article-title":"Premature epiphyseal closure in a child receiving oral 13-cis-retinoic acid","volume":"7","author":"Milstone","year":"1982","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib123","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0190-9622(86)70300-9","article-title":"Premature epiphyseal closure\u2014a complication of etretinate therapy in children","volume":"15","author":"Prendiville","year":"1986","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.yadr.2008.09.009_bib124","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2133.2005.06906.x","article-title":"Oral retinoid therapy for disorders of keratinization: single-centre retrospective 25 years' experience on 23 patients","volume":"154","author":"Katugampola","year":"2006","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib125","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0033-8389(22)00824-7","article-title":"Bony overgrowths and abnormal calcifications about the spine","volume":"26","author":"Jones","year":"1988","journal-title":"Radiol Clin North Am"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib126","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2133.2005.06605.x","article-title":"Noninvasive monitoring for methotrexate hepatotoxicity","volume":"152","author":"MacDonald","year":"2005","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib127","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0889-857X(05)70358-6","article-title":"The mechanism of action of methotrexate","volume":"23","author":"Cronstein","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.yadr.2008.09.009_bib128","series-title":"Comprehensive dermatologic drug therapy","first-page":"163","article-title":"Methotrexate","author":"Callen","year":"2007"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1525-1470.1994.tb00602.x","article-title":"Methotrexate in childhood psoriasis","volume":"11","author":"Kumar","year":"1994","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib130","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1525-1470.1985.tb01059.x","article-title":"Dermatologic uses of methotrexate in children: indications and guidelines","volume":"2","author":"Paller","year":"1985","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.yadr.2008.09.009_bib131","series-title":"Pediatric dermatology","first-page":"133","article-title":"Principles of treatment in pediatric dermatology: systemic treatment","author":"Swords","year":"2003"},{"issue":"8","key":"10.1016\/j.yadr.2008.09.009_bib132","first-page":"1570","article-title":"Influence of food on the bioavailability of oral methotrexate in children","volume":"22","author":"Dupuis","year":"1995","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.yadr.2008.09.009_bib133","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2230.1982.tb02465.x","article-title":"Intestinal function and methotrexate absorption in psoriatic patients","volume":"7","author":"Hendel","year":"1982","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib134","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.0736-8046.2004.21328.x","article-title":"Methotrexate in severe childhood psoriasis","volume":"21","author":"Dogra","year":"2004","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.yadr.2008.09.009_bib135","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/archpedi.1968.02100020220018","article-title":"Erythrodermic psoriasis in childhood. A young Negro child treated with methotrexate","volume":"116","author":"Scott","year":"1968","journal-title":"Am J Dis Child"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib136","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0022-3476(05)80923-0","article-title":"Morbidity associated with long-term methotrexate therapy in juvenile rheumatoid arthritis","volume":"120","author":"Graham","year":"1992","journal-title":"J Pediatr"},{"issue":"11","key":"10.1016\/j.yadr.2008.09.009_bib137","first-page":"2072","article-title":"The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg","volume":"22","author":"Kremer","year":"1995","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.yadr.2008.09.009_bib138","first-page":"1764","article-title":"Pilot investigation of naproxen\/methotrexate interaction in patients with juvenile rheumatoid arthritis","volume":"20","author":"Wallace","year":"1993","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib139","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0190-9622(87)80490-5","article-title":"Pancytopenia induced by the interaction between methotrexate and trimethoprim-sulfamethoxazole","volume":"17","author":"Thomas","year":"1987","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.yadr.2008.09.009_bib140","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/art.1780390214","article-title":"Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis","volume":"39","author":"Gutierrez-Urena","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib141","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/09546630701247930","article-title":"Folic acid in general medicine and dermatology","volume":"18","author":"Gisondi","year":"2007","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib142","first-page":"929","article-title":"Folic acid supplementation during methotrexate therapy: it makes sense","volume":"20","author":"Morgan","year":"1993","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib143","first-page":"441","article-title":"Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention","volume":"25","author":"Morgan","year":"1998","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.yadr.2008.09.009_bib144","doi-asserted-by":"crossref","first-page":"833","DOI":"10.7326\/0003-4819-121-11-199412010-00002","article-title":"Supplementation with folic acid during methotrexate\u00a0therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial","volume":"121","author":"Morgan","year":"1994","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/art.1780330102","article-title":"The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis","volume":"33","author":"Morgan","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.yadr.2008.09.009_bib146","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/1529-0131(200107)44:7<1515::AID-ART273>3.0.CO;2-7","article-title":"Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study","volume":"44","author":"van Ede","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib147","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0190-9622(98)70508-0","article-title":"Methotrexate in psoriasis: consensus conference","volume":"38","author":"Roenigk","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib148","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.4049\/jimmunol.144.6.2109","article-title":"Mechanism of action of cyclosporine A in vivo. II. T cell priming in vivo to alloantigen can be mediated by an IL-2-independent cyclosporine A-resistant pathway","volume":"144","author":"Pereira","year":"1990","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib149","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1365-2133.2000.03241.x","article-title":"Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy","volume":"142","author":"Harper","year":"2000","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.yadr.2008.09.009_bib150","first-page":"231","article-title":"Cyclosporin is safe and effective in severe atopic dermatitis of childhood. Report of three cases","volume":"56","author":"Leonardi","year":"2004","journal-title":"Minerva Pediatr"},{"issue":"Suppl 48","key":"10.1016\/j.yadr.2008.09.009_bib151","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2133.1996.tb00705.x","article-title":"Treatment of severe atopic dermatitis in childhood with cyclosporin","volume":"135","author":"Zaki","year":"1996","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.yadr.2008.09.009_bib152","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2133.1996.tb03889.x","article-title":"Consensus conference on cyclosporin A microemulsion for psoriasis, June 1996","volume":"135","author":"Berth-Jones","year":"1996","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib153","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1468-3083.2006.01562.x","article-title":"Cyclosporin A treatment in severe childhood psoriasis","volume":"20","author":"Pereira","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.yadr.2008.09.009_bib154","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/09546630310012136","article-title":"Cyclosporin in childhood psoriasis","volume":"14","author":"Perrett","year":"2003","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib155","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1365-2133.2002.04836.x","article-title":"Cyclosporin trough levels: is monitoring necessary during short-term treatment in psoriasis? A systematic review and clinical data on trough levels","volume":"147","author":"Heydendael","year":"2002","journal-title":"Br J Dermatol"},{"issue":"6 Pt 2","key":"10.1016\/j.yadr.2008.09.009_bib156","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/0190-9622(90)70354-K","article-title":"Laboratory monitoring of cyclosporine levels: guidelines for the dermatologist","volume":"23","author":"Mockli","year":"1990","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib157","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1046\/j.1365-2133.1998.02490.x","article-title":"The use of cyclosporin in a child with generalized pustular psoriasis","volume":"139","author":"Alli","year":"1998","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib158","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1525-1470.2001.018003246.x","article-title":"Low dose cyclosporin A treatment in generalized pustular psoriasis","volume":"18","author":"Kilic","year":"2001","journal-title":"Pediatr Dermatol"},{"issue":"11","key":"10.1016\/j.yadr.2008.09.009_bib159","first-page":"1532","article-title":"Cyclosporine in childhood psoriasis","volume":"137","author":"Mahe","year":"2001","journal-title":"Arch Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.yadr.2008.09.009_bib160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1365-4362.36.s1.3.x","article-title":"Safety issues with cyclosporine","volume":"36","author":"Ellis","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.yadr.2008.09.009_bib161","first-page":"229","article-title":"The treatment of psoriasis","volume":"24","author":"Goeckerman","year":"1925","journal-title":"Northwest Med"},{"issue":"2","key":"10.1016\/j.yadr.2008.09.009_bib162","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2133.2004.06128.x","article-title":"An update and guidance on narrowband ultraviolet B phototherapy: a British photodermatology group workshop report","volume":"151","author":"Ibbotson","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.yadr.2008.09.009_bib163","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.yadr.2005.03.001","article-title":"Narrowband ultraviolet B therapy for psoriasis and other skin disorders","volume":"21","author":"Kist","year":"2005","journal-title":"Adv Dermatol"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib164","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-4632.2007.03148.x","article-title":"Narrow-band UV-B phototherapy in childhood psoriasis","volume":"46","author":"Jain","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.yadr.2008.09.009_bib165","series-title":"Therapy of moderate to severe psoriasis","first-page":"53","article-title":"The art and practice of UVB phototherapy for the treatment of psoriasis","author":"Koo","year":"2003"},{"issue":"5","key":"10.1016\/j.yadr.2008.09.009_bib166","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1525-1470.1996.tb00711.x","article-title":"Experience with UVB phototherapy in children","volume":"13","author":"Tay","year":"1996","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.yadr.2008.09.009_bib167","series-title":"National Psoriasis Foundation Guide to Phototherapy","article-title":"Fundamentals of phototherapy","author":"McClelland","year":"2008"},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib168","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1525-1470.1995.tb00132.x","article-title":"UVB phototherapy in childhood psoriasis","volume":"12","author":"al-Fouzan","year":"1995","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib169","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1525-1470.2003.03016.x","article-title":"Phototherapy in pediatric patients","volume":"20","author":"Pasic","year":"2003","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib170","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1046\/j.1365-2133.2003.05482.x","article-title":"A randomized controlled trial of narrowband ultraviolet B vs bath-psoralen plus ultraviolet A photochemotherapy for psoriasis","volume":"148","author":"Dawe","year":"2003","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.yadr.2008.09.009_bib171","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/1523-1747.ep12520022","article-title":"Action spectrum for phototherapy of psoriasis","volume":"76","author":"Parrish","year":"1981","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib172","first-page":"212","article-title":"Comparison of narrow-band UV-B phototherapy and PUVA photochemotherapy in the treatment of psoriasis","volume":"70","author":"Van Weelden","year":"1990","journal-title":"Acta Derm Venereol"},{"issue":"6 Pt 1","key":"10.1016\/j.yadr.2008.09.009_bib173","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0190-9622(99)70076-9","article-title":"Suberythemogenic narrow-band UVB is markedly more effective than conventional UVB in treatment of psoriasis vulgaris","volume":"40","author":"Walters","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.yadr.2008.09.009_bib174","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1046\/j.1365-2133.1998.02221.x","article-title":"Narrow-band (TL-01) ultraviolet B phototherapy for chronic plaque psoriasis: three times or five times weekly treatment?","volume":"138","author":"Dawe","year":"1998","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.yadr.2008.09.009_bib175","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1034\/j.1600-0781.2000.160502.x","article-title":"Comparison of phototherapy two times and four times a week with low doses of narrow-band ultraviolet B in Asian patients with psoriasis","volume":"16","author":"Leenutaphong","year":"2000","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.yadr.2008.09.009_bib176","series-title":"Phototherapy treatment protocols: for psoriasis and other phototherapy responsive dermatoses","author":"Zanolli","year":"2005"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib177","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2133.1988.tb03489.x","article-title":"311 nm UVB phototherapy\u2014an effective treatment for psoriasis","volume":"119","author":"Green","year":"1988","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib178","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2230.2004.01504.x","article-title":"History of psoriasis response to sunlight does not predict outcome of UVB phototherapy","volume":"29","author":"Dawe","year":"2004","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib179","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2230.2005.01808.x","article-title":"A positive correlation between history of psoriasis response to sunlight and the response to UVB phototherapy. What are the consequences?","volume":"30","author":"Boer","year":"2005","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib180","first-page":"146","article-title":"Combination TL01 ultraviolet B phototherapy and topical calcipotriol for psoriasis: a prospective randomized placebo-controlled clinical trial","volume":"149","author":"Woo","year":"2003","journal-title":"Br\u00a0J\u00a0Dermatol"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib181","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0190-9622(00)90225-1","article-title":"Combination phototherapy of psoriasis with narrow-band UVB irradiation and topical tazarotene gel","volume":"42","author":"Behrens","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib182","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000018312","article-title":"Clinical efficacy of narrow-band UVB (311 nm) combined with dithranol in psoriasis. An open pilot study","volume":"200","author":"Carrozza","year":"2000","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib183","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0190-9622(97)70217-2","article-title":"Interactions between calcipotriene and ultraviolet light","volume":"37","author":"Lebwohl","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.yadr.2008.09.009_bib184","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/jdt.14.s2.17.20","article-title":"Retrospective study of the efficacy of narrowband UVB and acitretin","volume":"14","author":"Spuls","year":"2003","journal-title":"J Dermatolog Treat."},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib185","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1525-1470.2006.00247.x","article-title":"Two-stage therapy for childhood generalized pustular psoriasis: low-dose cyclosporin for induction and maintenance with acitretin\/narrowband ultraviolet B phototherapy","volume":"23","author":"Kim","year":"2006","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.yadr.2008.09.009_bib186","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000018342","article-title":"Blisters on psoriatic lesions treated with TL-01 lamps","volume":"200","author":"Calzavara-Pinton","year":"2000","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib187","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2133.1992.tb00470.x","article-title":"Lesional blistering following narrow-band (TL-01) UVB phototherapy for psoriasis: a report of four cases","volume":"127","author":"George","year":"1992","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.yadr.2008.09.009_bib188","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2133.2007.07980.x","article-title":"The challenge of follow-up in narrowband ultraviolet B phototherapy","volume":"157","author":"Diffey","year":"2007","journal-title":"Br\u00a0J Dermatol"},{"issue":"5","key":"10.1016\/j.yadr.2008.09.009_bib189","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1001\/archderm.143.5.586","article-title":"Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial","volume":"143","author":"Schiener","year":"2007","journal-title":"Arch Dermatol"},{"issue":"Suppl 36","key":"10.1016\/j.yadr.2008.09.009_bib190","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2133.1990.tb02889.x","article-title":"Side-effects of psoralen photochemotherapy (PUVA)","volume":"122","author":"Wolff","year":"1990","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib191","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000112924","article-title":"Bath PUVA and psoriasis: Is a milder treatment a worse treatment?","volume":"216","author":"Delrosso","year":"2008","journal-title":"Dermatology"},{"issue":"10","key":"10.1016\/j.yadr.2008.09.009_bib192","first-page":"593","article-title":"Comparative efficacy of psoralen-UVA photochemotherapy versus narrow band UVB phototherapy in the treatment of psoriasis","volume":"14","author":"Tahir","year":"2004","journal-title":"J Coll Physicians Surg Pak"},{"issue":"Suppl 2","key":"10.1016\/j.yadr.2008.09.009_bib193","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/jdt.14.s2.21.25","article-title":"Retrospective analysis of the treatment of psoriasis of the palms and soles","volume":"14","author":"Spuls","year":"2003","journal-title":"J Dermatolog Treat."},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib194","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1365-2133.2006.07217.x","article-title":"Treatment of erythrodermic psoriasis with etanercept","volume":"155","author":"Esposito","year":"2006","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib195","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1525-1470.2006.00174.x","article-title":"Etanercept for psoriasis in the pediatric population: experience in nine patients","volume":"23","author":"Hawrot","year":"2006","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib196","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa066886","article-title":"Etanercept treatment for children and adolescents with plaque psoriasis","volume":"358","author":"Paller","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib197","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2133.2005.06982.x","article-title":"Etanercept for the treatment of severe childhood psoriasis","volume":"154","author":"Papoutsaki","year":"2006","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.yadr.2008.09.009_bib198","first-page":"11","article-title":"Successful use of infliximab following a failed course of etanercept in a pediatric patient","volume":"11","author":"Farnsworth","year":"2005","journal-title":"Dermatol Online J"},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib199","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.0736-8046.2004.21121.x","article-title":"Successful treatment of pediatric psoriasis with infliximab","volume":"21","author":"Menter","year":"2004","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib200","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000096202","article-title":"Anti-TNF-alpha therapy in childhood pustular psoriasis","volume":"213","author":"Pereira","year":"2006","journal-title":"Dermatology"},{"issue":"7","key":"10.1016\/j.yadr.2008.09.009_bib201","first-page":"4","article-title":"TNF-alpha inhibitors in dermatology","volume":"12","author":"Cordoro","year":"2007","journal-title":"Skin Therapy Lett"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib202","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0022-3476(88)80577-8","article-title":"Guttate psoriasis associated with perianal streptococcal disease","volume":"113","author":"Honig","year":"1988","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib203","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0733-8635(18)30848-9","article-title":"Psoriasis in children","volume":"4","author":"Rasmussen","year":"1986","journal-title":"Dermatol Clin"},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib204","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1525-1470.2003.03003.x","article-title":"Treatment of psoriasis in children: is there a role for antibiotic therapy and tonsillectomy?","volume":"20","author":"Wilson","year":"2003","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib205","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1046\/j.1365-2133.2001.04504.x","article-title":"A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis","volume":"145","author":"Owen","year":"2001","journal-title":"Br J Dermatol"},{"issue":"7128","key":"10.1016\/j.yadr.2008.09.009_bib206","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.yadr.2008.09.009_bib207","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.0022-202X.2004.23448.x","article-title":"A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis","volume":"123","author":"Kauffman","year":"2004","journal-title":"J Invest Dermatol"},{"issue":"10","key":"10.1016\/j.yadr.2008.09.009_bib208","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/ard.2003.016337","article-title":"Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene","volume":"63","author":"Berkun","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.yadr.2008.09.009_bib209","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.jid.5700096","article-title":"Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis","volume":"126","author":"Young","year":"2006","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.yadr.2008.09.009_bib210","first-page":"26","article-title":"Childhood psoriasis","volume":"39","author":"Hutton","year":"1987","journal-title":"Cutis"},{"issue":"5","key":"10.1016\/j.yadr.2008.09.009_bib211","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1600-0536.1992.tb03282.x","article-title":"Dithranol allergy: fact or fiction?","volume":"27","author":"Burden","year":"1992","journal-title":"Contact Derm"},{"issue":"4","key":"10.1016\/j.yadr.2008.09.009_bib212","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-4362.1997.00176.x","article-title":"Coal tar therapy in palmoplantar psoriasis: old wine in an old bottle?","volume":"36","author":"Kumar","year":"1997","journal-title":"Int J Dermatol"},{"issue":"10","key":"10.1016\/j.yadr.2008.09.009_bib213","first-page":"2249","article-title":"Two cases of methotrexate induced lymphomas in rheumatoid arthritis: an association with increased serum IgE","volume":"26","author":"Kono","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.yadr.2008.09.009_bib214","series-title":"Comprehensive dermatologic drug therapy","first-page":"219","article-title":"Cyclosporine","author":"Lee","year":"2007"}],"container-title":["Advances in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882088008000035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882088008000035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T09:54:25Z","timestamp":1684662865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882088008000035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":214,"alternative-id":["S0882088008000035"],"URL":"https:\/\/doi.org\/10.1016\/j.yadr.2008.09.009","relation":{},"ISSN":["0882-0880"],"issn-type":[{"value":"0882-0880","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}